ULCUR

ULCUR

Marketed by: Schering Oy
Active ingredient: Cimetidinum
Other information: tablet - 200 mg

Available in: Finland
Language: English
Source: Fimea

ULCUR

ULCUR

Marketed by: Schering Oy
Active ingredient: Cimetidinum
Other information: injection - 100 mg/ml

Available in: Finland
Language: English
Source: Fimea

ULCUR

ULCUR

Marketed by: Schering Oy
Active ingredient: Cimetidinum
Other information: oral liquid - 40 mg/ml

Available in: Finland
Language: English
Source: Fimea

ULZATE - PANTOPRAZOLE PHARMASCOPE

ULZATE - PANTOPRAZOLE PHARMASCOPE

Marketed by: TEVA Sweden AB
Active ingredient: Pantoprazolum natricum sesquihydricum
Other information: gastro-resistant tablet - 20 mg

Available in: Finland
Language: English
Source: Fimea

ULZATE - PANTOPRAZOLE PHARMASCOPE

ULZATE - PANTOPRAZOLE PHARMASCOPE

Marketed by: TEVA Sweden AB
Active ingredient: Pantoprazolum natricum sesquihydricum
Other information: gastro-resistant tablet - 40 mg

Available in: Finland
Language: English
Source: Fimea

ULCOBAN PROLONGATUM - PORTYN PROLONGATUM

ULCOBAN PROLONGATUM - PORTYN PROLONGATUM

Marketed by: Parke Davis & Co. Ltd.
Active ingredient: Benzilonii bromidum
Other information: prolonged-release tablet - 35 mg

Available in: Finland
Language: English
Source: Fimea

URO-GASTROSEDAN - NEO-GASTROSEDAN

URO-GASTROSEDAN - NEO-GASTROSEDAN

Marketed by: Schering Oy
Active ingredient: Propanthelini bromidum
Other information: tablet - 15 mg

Available in: Finland
Language: English
Source: Fimea

INSULIN ULTRATARD HUMAN

INSULIN ULTRATARD HUMAN

Marketed by: Novo Nordisk A/S
Active ingredient: Insulinum monocomponent. (humanum)
Other information: suspension for injection - 100 IU/ml

Available in: Finland
Language: English
Source: Fimea

ULTRADUR INSULIN

ULTRADUR INSULIN

Marketed by: MEDICA
Active ingredient: Insulinum crystallisatum (bovine)
Other information: injection - 40 IU/ml

Available in: Finland
Language: English
Source: Fimea

UROVISON

UROVISON

Marketed by: Schering Oy
Active ingredient:
Other information: injection

Available in: Finland
Language: English
Source: Fimea

UROSORB - KYSTOSOL

UROSORB - KYSTOSOL

Marketed by: Schering Oy
Active ingredient: Sorbitolum
Other information: irrigation solution

Available in: Finland
Language: English
Source: Fimea

UROGLYSIN

UROGLYSIN

Marketed by: Schering Oy
Active ingredient: Acidum aminoaceticum
Other information: irrigation solution - 22 mg/ml

Available in: Finland
Language: English
Source: Fimea

UROGLYS-H

UROGLYS-H

Marketed by: Schering Oy
Active ingredient: Acidum aminoaceticum,Acidum hippuricum
Other information: irrigation solution

Available in: Finland
Language: English
Source: Fimea

URINEX

URINEX

Marketed by: Orion Oyj
Active ingredient: Chlorothiazidum
Other information: tablet - 500 mg

Available in: Finland
Language: English
Source: Fimea

URETREN

URETREN

Marketed by: Orion Oyj
Active ingredient: Triamterenum
Other information: tablet - 50 mg

Available in: Finland
Language: English
Source: Fimea

URETREN COMP

URETREN COMP

Marketed by: Orion Oyj
Active ingredient: Trichlormethiazidum,Triamterenum
Other information: tablet

Available in: Finland
Language: English
Source: Fimea

ULTRAPROCT

ULTRAPROCT

Marketed by: Schering Oy
Active ingredient: Clemizoli undecylenas,Hexachlorophenum,Cinchocaini hydrochloridum,Fluocortoloni caproas,Fluocortoloni pivalas
Other information: suppository

Available in: Finland
Language: English
Source: Fimea

ULTRAPROCT

ULTRAPROCT

Marketed by: Schering Oy
Active ingredient: Cinchocaini hydrochloridum,Fluocortoloni caproas,Fluocortoloni pivalas,Hexachlorophenum,Clemizoli undecylenas
Other information: rectal ointment

Available in: Finland
Language: English
Source: Fimea

UNILOC

UNILOC

Marketed by: Nycomed Oy
Active ingredient: Atenololum
Other information: tablet - 25 mg

Available in: Finland
Language: English
Source: Fimea

UNILOC

UNILOC

Marketed by: Nycomed Oy
Active ingredient: Atenololum
Other information: tablet - 50 mg

Available in: Finland
Language: English
Source: Fimea

UNILOC

UNILOC

Marketed by: Nycomed Oy
Active ingredient: Atenololum
Other information: tablet - 100 mg

Available in: Finland
Language: English
Source: Fimea

UNIDIPIN

UNIDIPIN

Marketed by: Pharmacia & Upjohn S.P.A.
Active ingredient: Nifedipinum
Other information: prolonged-release tablet - 20 mg

Available in: Finland
Language: English
Source: Fimea

UNIDIPIN

UNIDIPIN

Marketed by: Pharmacia & Upjohn S.P.A.
Active ingredient: Nifedipinum
Other information: prolonged-release tablet - 50 mg

Available in: Finland
Language: English
Source: Fimea

UNIMAX MITE

UNIMAX MITE

Marketed by: AstraZeneca Oy
Active ingredient: Ramiprilum,Felodipinum
Other information: prolonged-release tablet

Available in: Finland
Language: English
Source: Fimea

UNIMAX

UNIMAX

Marketed by: AstraZeneca Oy
Active ingredient: Felodipinum,Ramiprilum
Other information: prolonged-release tablet

Available in: Finland
Language: English
Source: Fimea

UNIDERM

UNIDERM

Marketed by: Schering-Plough Europe
Active ingredient: Hydrocortisonum
Other information: cutaneous solution - 1 %

Available in: Finland
Language: English
Source: Fimea

ULTRALAN-S

ULTRALAN-S

Marketed by: Schering Oy
Active ingredient: Fluocortoloni caproas,Fluocortolonum hydratum
Other information: ointment

Available in: Finland
Language: English
Source: Fimea

ULTRALAN S

ULTRALAN S

Marketed by: Schering Oy
Active ingredient: Fluocortoloni pivalas,Fluocortoloni caproas
Other information: cream

Available in: Finland
Language: English
Source: Fimea

ULTRALAN

ULTRALAN

Marketed by: Schering Oy
Active ingredient: Fluocortolonum hydratum,Clemizoli hexachlorophenum,Fluocortoloni caproas
Other information: ointment

Available in: Finland
Language: English
Source: Fimea

UTOPAR

UTOPAR

Marketed by: Ferrosan A/S
Active ingredient: Ritodrini hydrochloridum
Other information: injection - 10 mg/ml

Available in: Finland
Language: English
Source: Fimea